riluzole has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, S; Jang, SJ; Kim, I; Lee, HY; Lee, SE; Park, S; Seol, HS; Singh, SR; Song, JS | 1 |
| Chang, CH; Chen, WC; Chow, CK; Jan, CR; Law, YP; Lee, KC; Lu, T; Su, W; Tang, KY; Wang, JL | 1 |
2 other study(ies) available for riluzole and Cancer of Liver
| Article | Year |
|---|---|
Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Repositioning; Excitatory Amino Acid Antagonists; G2 Phase Cell Cycle Checkpoints; Glutamic Acid; Glutathione; Humans; Liver Neoplasms; Male; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Oxidative Stress; Reactive Oxygen Species; Riluzole; Signal Transduction; Tumor Burden; Tumor Cells, Cultured; Up-Regulation; Xenograft Model Antitumor Assays | 2016 |
Effect of the neuroprotective agent riluzole on intracellular Ca2+ levels in IMR32 neuroblastoma cells.
Topics: Animals; Brefeldin A; Calcium; Calcium Channel Blockers; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line; Dogs; Enzyme Inhibitors; Fura-2; Glioma; Humans; Ionophores; Kidney; Liver Neoplasms; Neuroblastoma; Neurons; Neuroprotective Agents; Protein Synthesis Inhibitors; Riluzole; Thapsigargin; Tumor Cells, Cultured | 2001 |